Integra Lifesciences Holdings (IART) Free Cash Flow (QoQ) (2009 - 2026)
Integra Lifesciences Holdings (IART) Free Cash Flow (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn |
| 3 | Medtronic | 108.10 Bn | 98.88 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.99 Bn | 66.53 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.15 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - |
| 9 | Koninklijke Philips | 23.74 Bn | 20.62 Bn | 2.07 Bn |
| 10 | Integra Lifesciences Holdings | 1.50 Bn | 1.24 Bn | 216.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.54% |
| Dec 31, 2025 | -120.96% |
| Sep 30, 2025 | 329.36% |
| Jun 30, 2025 | 72.06% |
| Mar 31, 2025 | -290.05% |
| Dec 31, 2024 | 395.21% |
| Sep 30, 2024 | -166.96% |
| Jun 30, 2024 | 3,574.91% |
| Mar 31, 2024 | -99.15% |
| Dec 31, 2023 | 149.89% |
| Sep 30, 2023 | 7.55% |
| Jun 30, 2023 | 2.24% |
| Mar 31, 2023 | -82.43% |
| Dec 31, 2022 | 19.81% |
| Sep 30, 2022 | 3.66% |
| Jun 30, 2022 | 62.97% |
| Mar 31, 2022 | -16.32% |
| Dec 31, 2021 | -44.56% |
| Sep 30, 2021 | -10.82% |
| Jun 30, 2021 | 35.65% |